Advances in the role of intestinal ion channels in the pathogenesis of irritable bowel syndrome

Abstract

Abstract: Ion channels are widely present in mucous membranes of the digestive tract, their abnormal expression and(or) function are important pathogenic mechanisms of irritable bowel syndrome (IBS). The plasma channels of voltage-gated sodium channels (VGSCs), voltage-gated calcium channels (VGCCs) and transient receptor potential channels (TRPs) are involved in IBS gastrointestinal motility and visceral hypersensitivity to varying degrees. They are key pathophysiological and therapeutic targets for regulating gastrointestinal motility and visceral hypersensitivity.

Key words: irritable bowel syndrome, pathogenesis, ion channels

CLC Number:

R574.4

LAN Fei, LIU Tai-yang, YANG Jie. Advances in the role of intestinal ion channels in the pathogenesis of irritable bowel syndrome[J]. Basic & Clinical Medicine, 2020, 40(8): 1135-1139.

References

[1] Kageyama Y, Aida K, Kawauchi K, et al. Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome[J]. Immun Inflamm Dis, 2019, 7:304-307.
[2] Baj A, Bistoletti M, Bosi A, et al. Marine toxins and nociception: potential therapeutic use in the treatment of visceral pain associated with gastrointestinal disorders[J]. Toxins, 2019, 11:1-37.
[3] Chalazonitis A, Rao M. Enteric nervous system manifestations of neurodegenerative disease[J]. Brain Res, 2018, 1693:207-213.
[4] Nagy N, Goldstein AM. Enteric nervous system development: a crest cell's journey from neural tube to colon[J]. Semin Cell Dev Biol, 2017, 66:94-106.
[5] Cryan JF, O'Riordan KJ, Cowan C, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99:1877-2013.
[6] Scanzi J, Accarie A, Muller E, et al. Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients[J]. Neurogastroenterol Motil, 2016, 28: 1632-1640.
[7] Hull JM, Isom LL. Voltage-gated sodium channel β subunits: the power outside the pore in brain development and disease[J]. europharmacology, 2018, 132:43-57.
[8] 郭子涵, 赵正, 刘晓, 等. 离子通道与肠易激综合征发病机制的研究进展[J]. 胃肠病学, 2019, 24:501-504.
[9] Saito YA, Strege PR, Tester DJ, et al. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 296:G211-G218.
[10] Strege PR, Mazzone A, Bernard CE, et al. Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity[J]. Am J Physiol Gastrointest Liver Physiol, 2018, 314:G494-G503.
[11] Zamponi GW, Striessnig J, Koschak A, et al. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential[J]. Pharmacol Rev, 2015, 67:821-870.
[12] Gadotti VM, Zamponi GW. Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation[J]. Mol Brain, 2018, 11:60-62.
[13] Zhu J, Luo HS, Chen L, et al. Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome[J]. CMJ, 2009, 89:2713-2717.
[14] Qian A, Song D, Li Y, et al. Role of voltage gated Ca²⁺ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid[J]. Mol Pain, 2013, 9:15-24.
[15] Picard E, Carvalho FA, Agosti F, et al. Inhibition of Cav 3.2 calcium channels: a new target for colonic hypersensitivity associated with low-grade inflammation[J]. Br J Pharmacol, 2019, 176:950-963.
[16] Balemans D, Boeckxstaens GE, Talavera K, et al. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312:G635-G648.
[17] Csekö K, Beckers B, Keszthelyi D, et al. Role of TRPV1 and TRPA1 ion channels in inflammatory bowel diseases: potential therapeutic targets?[J]. Pharmaceuticals, 2019, 12:48-66.
[18] Zhou Q, Yang L, Larson S, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1[J]. Gut, 2016, 65:797-805.
[19] Xu XJ, Zhang YL, Liu L, et al. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study[J]. Aliment Pharmacol Ther, 2017, 45:100-114.
[20] Beckers AB, Weerts Z, Helyes Z, et al. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2017, 46:938-952.
[21] Balemans D, Aguilera-Lizarraga J, Florens MV, et al. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316: G338-G349.
[22] de Jong PR, Takahashi N, Peiris M, et al. TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via GRP[J]. Mucosal Immunol, 2015, 8: 491-504.
[23] Henström M, Hadizadeh F, Beyder A, et al. TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M[J]. Gut, 2017, 66: 1725-1727.